| Literature DB >> 27995149 |
Ali Hassan Alhaiti1, Alanod Raffa Alotaibi2, Linda Katherine Jones3, Cliff DaCosta4, George Binh Lenon3.
Abstract
Objective. To translate the revised Michigan Diabetes Knowledge Test into the Arabic language and examine its psychometric properties. Setting. Of the 139 participants recruited through King Fahad Medical City in Riyadh, Saudi Arabia, 34 agreed to the second-round sample for retesting purposes. Methods. The translation process followed the World Health Organization's guidelines for the translation and adaptation of instruments. All translations were examined for their validity and reliability. Results. The translation process revealed excellent results throughout all stages. The Arabic version received 0.75 for internal consistency via Cronbach's alpha test and excellent outcomes in terms of the test-retest reliability of the instrument with a mean of 0.90 infraclass correlation coefficient. It also received positive content validity index scores. The item-level content validity index for all instrument scales fell between 0.83 and 1 with a mean scale-level index of 0.96. Conclusion. The Arabic version is proven to be a reliable and valid measure of patient's knowledge that is ready to be used in clinical practices.Entities:
Mesh:
Year: 2016 PMID: 27995149 PMCID: PMC5141566 DOI: 10.1155/2016/9643714
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Flowchart depicting the processes used for the translation and validation of the instrument.
Expert panel characteristics.
| ID | Gender | Profession | Work in healthcare | Diabetes experience (years) |
|---|---|---|---|---|
| 1 | F | Head nurse | Yes | 3 |
| 2 | F | Staff nurse | Yes | 8 |
| 3 | F | Head of diabetes education | Yes | 6 |
| 4 | M | Nurse manager | Yes | 14 |
| 5 | M | Staff nurse 1 | Yes | 10 |
| 6 | F | Nursing student | No | 0 |
| 7 | M | Clinical-research consultant | Yes | 22 |
| 8 | F | Nurse | Yes | 1.5 |
| 9 | M | Translator | Yes | 0 |
Demographics.
| Characteristics | Frequency ( | Percent % |
|---|---|---|
|
| ||
| Good control | 28 | 20.1 |
| Acceptable control | 39 | 28.1 |
| Poor control | 71 | 51.1 |
| Missing | 1 | 0.7 |
|
| ||
|
| ||
| 18–30 years | 56 | 40.3 |
| 3–45 years | 34 | 24.5 |
| 46–55 years | 20 | 14.4 |
| >56 years | 25 | 18 |
| Missing | 4 | 2.9 |
|
| ||
|
| ||
| Male | 62 | 44.6 |
| Female | 74 | 53.2 |
| Missing | 3 | 2.2 |
|
| ||
|
| ||
| <5.000 | 56 | 40.3 |
| <10.000 | 44 | 31.7 |
| <15.000 | 14 | 10.1 |
| >16.000 | 19 | 13.7 |
| Missing | 6 | 4.3 |
|
| ||
|
| ||
| Currently | 16 | 11.5 |
| No | 95 | 68.3 |
| Yes | 14 | 10.1 |
| Missing | 14 | 10.1 |
|
| ||
|
| ||
| <2 years | 7 | 5.0 |
| 2–4 years | 18 | 12.9 |
| 5–7 years | 27 | 19.4 |
| 8–10 years | 21 | 15.1 |
| >10 years | 61 | 43.9 |
| Missing | 5 | 3.6 |
|
| ||
|
| ||
| Elementary-school | 16 | 11.5 |
| Middle-school | 14 | 10.1 |
| High-school | 45 | 32.4 |
| Bachelor | 57 | 41.0 |
| Postgraduate | 4 | 2.9 |
| Missing | 3 | 2.2 |
|
| ||
|
| ||
| Cardiac | 7 | 5.0 |
| Bp | 13 | 9.4 |
| Kidney | 3 | 2.0 |
| Eye | 20 | 14.4 |
| >1 | 53 | 38.1 |
| Missing | 43 | 30.9 |
Intraclass correlation coefficient (ICC).
| Intraclass correlationb | 95% confidence interval |
| |||||
|---|---|---|---|---|---|---|---|
| Lower-bound | Upper-bound | Value | df1 | df2 | Sign | ||
| Single measures | 0.822a | 0.573 | 0.920 | 13.418 | 33 | 33 | 0.000 |
| Average measures | 0.903c | 0.729 | 0.958 | 13.418 | 33 | 33 | 0.000 |
Note. Two-way mixed-effects model where people effects are random and measures effects are fixed.
aThe estimator is the same whether the interaction effect is present or not.
bType A ICCs using an absolute agreement definition.
cTo achieve an estimate, this number is computed assuming the interaction effect is absent.
Content validity index (CVI).
| Item description | Expert | Number of agreements | I-CVI | |||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |||
| Scale item 1 | 3 | 3 | 4 | 3 | 4 | 4 | 6 | 1 |
| Scale item 2 | 3 | 3 | 3 | 4 | 3 | 4 | 6 | 1 |
| Scale item 3 | 4 | 3 | 4 | 3 | 3 | 3 | 6 | 1 |
| Scale item 4 | 3 | 3 | 3 | 4 | 3 | 2 | 5 | 0.833 |
| Scale item 5 | 4 | 3 | 2 | 4 | 4 | 4 | 5 | 0.833 |
| Scale item 6 | 4 | 4 | 3 | 3 | 4 | 4 | 6 | 1 |
| Scale item 7 | 4 | 3 | 4 | 3 | 4 | 4 | 6 | 1 |
| Scale item 8 | 4 | 4 | 4 | 4 | 4 | 3 | 6 | 1 |
| Scale item 9 | 3 | 4 | 3 | 3 | 2 | 3 | 5 | 0.833 |
| Scale item 10 | 3 | 4 | 3 | 3 | 4 | 4 | 6 | 1 |
| Scale item 11 | 4 | 3 | 4 | 3 | 4 | 3 | 6 | 1 |
| Scale item 12 | 3 | 3 | 3 | 4 | 3 | 4 | 6 | 1 |
| Scale item 13 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 1 |
| Scale item 14 | 4 | 4 | 4 | 3 | 4 | 4 | 6 | 1 |
| S-CVI/Ave |
| |||||||
| Total agreement |
| |||||||
| S-CVI/UA |
| |||||||